![](/img/cover-not-exists.png)
989TiPOCTOVA: A randomised phase II trial of olaparib, chemotherapy, or olaparib and cediranib in patients with BRCA-mutated platinum-resistant ovarian cancer
Nicum, S., Strauss, V.Y., McGregor, N., McNeish, I., Roux, R., Hall, M., Michael, A., Roberts, C.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx372.060
Date:
September, 2017
File:
PDF, 50 KB
english, 2017